Wealth Enhancement Advisory Services LLC Invests $244,000 in Doximity, Inc. (NASDAQ:DOCS)

Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 4,575 shares of the company’s stock, valued at approximately $244,000.

Several other institutional investors also recently bought and sold shares of DOCS. QSV Equity Investors LLC boosted its holdings in shares of Doximity by 0.3% during the 4th quarter. QSV Equity Investors LLC now owns 60,763 shares of the company’s stock valued at $3,244,000 after acquiring an additional 186 shares during the last quarter. Handelsbanken Fonder AB grew its holdings in Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock valued at $1,586,000 after buying an additional 200 shares in the last quarter. Fielder Capital Group LLC grew its holdings in shares of Doximity by 4.5% in the fourth quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock valued at $293,000 after purchasing an additional 235 shares in the last quarter. Larson Financial Group LLC grew its holdings in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after purchasing an additional 250 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC grew its holdings in shares of Doximity by 17.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 2,269 shares of the company’s stock valued at $121,000 after purchasing an additional 332 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the completion of the transaction, the director now directly owns 16,618 shares of the company’s stock, valued at approximately $946,062.74. The trade was a 10.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Anna Bryson sold 45,000 shares of the company’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the transaction, the chief financial officer now directly owns 357,165 shares of the company’s stock, valued at approximately $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 51,000 shares of company stock worth $2,900,770 over the last quarter. Insiders own 37.40% of the company’s stock.

Doximity Stock Up 0.2%

Shares of NASDAQ DOCS opened at $56.03 on Tuesday. The business’s 50 day moving average price is $55.24 and its 200 day moving average price is $58.52. The firm has a market cap of $10.52 billion, a P/E ratio of 56.03, a P/E/G ratio of 4.10 and a beta of 1.32. Doximity, Inc. has a 52 week low of $25.00 and a 52 week high of $85.21.

Doximity (NASDAQ:DOCS) last issued its earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The company’s revenue was up 17.1% compared to the same quarter last year. During the same period last year, the company earned $0.25 EPS. As a group, research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Wall Street Analyst Weigh In

DOCS has been the subject of several recent analyst reports. Canaccord Genuity Group dropped their price objective on shares of Doximity from $71.00 to $50.00 and set a “hold” rating for the company in a research note on Friday, May 16th. Raymond James decreased their price objective on Doximity from $83.00 to $65.00 and set an “outperform” rating for the company in a report on Friday, May 16th. The Goldman Sachs Group set a $50.00 target price on shares of Doximity and gave the stock a “neutral” rating in a report on Wednesday, May 21st. Truist Financial reduced their target price on shares of Doximity from $58.00 to $52.00 and set a “hold” rating for the company in a report on Friday, May 16th. Finally, Morgan Stanley reduced their target price on shares of Doximity from $71.00 to $60.00 and set an “equal weight” rating for the company in a report on Thursday, April 24th. Eleven equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $62.84.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.